GLP-1 drugs like Ozempic have long helped people eat less — now, they’re showing promise in helping people crave less. A new analysis of records from over 600,000 diabetic veterans found that GLP-1 ...

Last April, neuroscientist Sue Grigson received an e-mail from a man detailing his years-long struggle to kick addiction — first to opioids, and then to the very medication meant to help him quit. The ...

My life changed 20 years ago, when my friend and I were floating down the Rogue River in Oregon. Suddenly the motor fell off the boat, which tipped over. I slipped into the icy water. Some young ...

When you read about addiction statistics in our community, our country and around the world, you may think, “well, that’s a lot of people who made pretty bad decisions.” That is, if you’re one of the ...

School’s out. Teens are bored. And the siren call of social media and video games beckons. Parents and caregivers bungling through new summer routines, or lack thereof, have long sought to balance the ...

How political red tape and a drug company’s thirst for profits limited the reach of a drug that experts believe could have reduced the opioid epidemic’s toll. Credit...Photo illustration by Ben Denzer ...

First-person stories of drug addiction, hope, healing, and recovery. Addiction is a complex and often misunderstood condition. This gripping special provides raw, unfiltered access to first-person ...

Prescription weight loss drugs have been lauded as the miracle drug for treating diabetes and obesity, but new research suggests that these drugs, known as glucagon-like peptide-1 (GLP-1) ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

Ms. Szalavitz is a contributing Opinion writer. Jessica Massarone couldn’t concentrate in primary school: She was too preoccupied with her parents’ struggles with drug addiction. Sometimes, she’d find ...